IJsselstein, May 5 (ANI/Business Wire India): In line with its strategic objective to build a global network of service centers in close proximity to leading genomics researchers, Ocimum Biosolutions B.V. today announced the launch of genomic services on Affymetrix platform from Europe.
Initially Ocimum will service Gene Expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire bouquet of services from its IJsselstein facility.
"Ocimum-Gene Logic is focused on providing high quality, validated and industry leading services to our clients worldwide. With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading lifescience companies and research centers in Europe," said Anu Acharya, CEO, Ocimum Biosolutions and Gene Logic.
"Having replicated the same protocols which are used in our GLP compliant Gaithersburg facility, our European center would also now generate and analyze genomic and gene expression data with the same quality and attention to detail that make us the partner of choice for two-thirds of the top 25 pharmaceutical/biotech companies and research centers," added Acharya."We share a long-standing and deep relationship with Ocimum-Gene Logic," said Kevin King, President and CEO of Affymetrix.
"Gene Logic has been an Authorized Service Provider for Affymetrix for more than a decade, providing genomic services on the Affymetrix platform from its Gaithersburg lab, which is one of the largest commercial microarray facilities in the world. We are very proud to be associated with this exciting expansion," added King. (ANI)